ArticleScience advances2026
Superenhancers shape the landscape and repair dynamics of transcription-associated DNA breaks in cancer.
Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- From cell to disease: Regulatory networks and mechanisms of super‑enhancers in aging (Review).Molecular medicine reports · 2026Review
- Transcription-Coupled Repair Promotes the Retention of Mutations in Coding Regions During Replication Stress.International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer is characterized by uncontrolled proliferation accompanied by oncogene hypertranscription, leading to transcription stress, a key source of DNA double-strand breaks (DSBs) that jeopardize genomic stability. Despite its importance, the landscape and consequences of transcription stress remain underexplored. Here, we used maps of DSBs identified through sBLISS (in-suspension break labeling in situ and sequencing) with transcription stress markers to delineate the transcription stress landscape in cancer. We found that transcription stress sites are shaped by the superenhancer regulatory landscape. Notably, γH2AX is enriched at transcription stress sites; however, not all DSB-enriched genes show similar γH2AX marking. Instead, genes with DSBs tied to transcription stress are distinctly marked. Genes with high DSBs marked by γH2AX exhibited substantially higher DSB turnover and repair than those with low γH2AX, and are associated with vulnerability to mutagenesis. These findings underscore superenhancer activity as a determinant of the transcription stress landscape in cancer, posing a threat to the genomic stability of oncogenes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.